ArticleBMC health services research2022

Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.

Alen Brkic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.